IRSA PROPIEDADES COMERCI-ADR (IRCP) Fundamental Analysis & Valuation

NASDAQ:IRCP • US4635881034

Current stock price

2.4984
+0.14 (+5.86%)
Last:

This IRCP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IRCP Profitability Analysis

1.1 Basic Checks

IRCP Yearly Net Income VS EBIT VS OCF VS FCFIRCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 20B -20B

1.2 Ratios

Industry RankSector Rank
ROA -17.47%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IRCP Yearly ROA, ROE, ROICIRCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40 60 -60

1.3 Margins

Industry RankSector Rank
OM 35.92%
PM (TTM) -184.81%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IRCP Yearly Profit, Operating, Gross MarginsIRCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 100 -100 200 300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. IRCP Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for IRCP remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, IRCP has an improved debt to assets ratio.
IRCP Yearly Shares OutstandingIRCP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
IRCP Yearly Total Debt VS Total AssetsIRCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 50B 100B 150B 200B

2.2 Solvency

  • A Debt/Equity ratio of 0.48 indicates that IRCP is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
IRCP Yearly LT Debt VS Equity VS FCFIRCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 20B 40B 60B 80B 100B

2.3 Liquidity

  • IRCP has a Current Ratio of 1.89. This is a normal value and indicates that IRCP is financially healthy and should not expect problems in meeting its short term obligations.
  • IRCP has a Quick Ratio of 1.88. This is a normal value and indicates that IRCP is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.88
IRCP Yearly Current Assets VS Current LiabilitesIRCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 5B 10B 15B 20B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. IRCP Growth Analysis

3.1 Past

  • The earnings per share for IRCP have decreased strongly by -180.04% in the last year.
  • The Revenue has decreased by -9.54% in the past year.
  • The Revenue has been growing by 23.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-180.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.9%
Revenue 1Y (TTM)-9.54%
Revenue growth 3Y0.33%
Revenue growth 5Y23.32%
Sales Q2Q%95.46%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year30.42%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IRCP Yearly Revenue VS EstimatesIRCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 5B 10B 15B 20B
IRCP Yearly EPS VS EstimatesIRCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 0 200 400

More info and screens

Find the best growth stocksShow best growing peers

0

4. IRCP Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
IRCP Price Earnings VS Forward Price EarningsIRCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRCP Per share dataIRCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. IRCP Dividend Analysis

5.1 Amount

  • IRCP has a Yearly Dividend Yield of 14.23%, which is a nice return.
  • Compared to an average S&P500 Dividend Yield of 1.89, IRCP pays a better dividend.
Industry RankSector Rank
Dividend Yield 14.23%

5.2 History

  • On average, the dividend of IRCP grows each year by 142.52%, which is quite nice.
  • IRCP has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)142.52%
Div Incr YearsN/A
Div Non Decr YearsN/A
IRCP Yearly Dividends per shareIRCP Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
IRCP Yearly Income VS Free CF VS DividendIRCP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 0 20B -20B

More info and screens

Find the best dividend stocksShow peers with best dividend

IRCP Fundamentals: All Metrics, Ratios and Statistics

IRSA PROPIEDADES COMERCI-ADR

NASDAQ:IRCP (5/27/2022, 8:11:24 PM)

2.4984

+0.14 (+5.86%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-01
Earnings (Next)N/A
Inst Owners0.02%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap338.05M
Revenue(TTM)17.66B
Net Income(TTM)-32.63B
Analysts86.67
Price Target2.55 (2.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 14.23%
Yearly Dividend17.94
Dividend Growth(5Y)142.52%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.47%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 35.92%
PM (TTM) -184.81%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.89
Quick Ratio 1.88
Altman-Z N/A
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.54%
Revenue growth 3Y0.33%
Revenue growth 5Y23.32%
Sales Q2Q%95.46%
Revenue Next Year30.42%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

IRSA PROPIEDADES COMERCI-ADR / IRCP Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for IRSA PROPIEDADES COMERCI-ADR?

ChartMill assigns a fundamental rating of 2 / 10 to IRCP.


What is the valuation status of IRSA PROPIEDADES COMERCI-ADR (IRCP) stock?

ChartMill assigns a valuation rating of 0 / 10 to IRSA PROPIEDADES COMERCI-ADR (IRCP). This can be considered as Overvalued.


How profitable is IRSA PROPIEDADES COMERCI-ADR (IRCP) stock?

IRSA PROPIEDADES COMERCI-ADR (IRCP) has a profitability rating of 1 / 10.